Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Vasc Interv Radiol ; 22(4): 462-70, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21367617

ABSTRACT

PURPOSE: To evaluate the clinical and imaging effect of selective embolization using N-butyl cyanoacrylate (NBCA) as palliation for bone metastases. MATERIALS AND METHODS: The procedures and effect of 309 embolizations performed in 243 patients were retrospectively analyzed; 56 patients had repeat embolization at the same location at 1-3 months; 197 patients had embolization for progressive bone metastases after radiation therapy. The mean tumor diameter before embolization was 7.8 cm (range 5-30 cm). In all patients, embolizations were performed under local anesthesia through transfemoral catheterization using NBCA in 33% ethiodized oil. The technical success of embolization was evaluated by angiography after completion of the procedure. The clinical and imaging effect was evaluated at follow-up examinations with a pain score scale and use of analgesics, hypoattenuating areas, tumor size, and ossification. RESULTS: In all 309 embolizations, postprocedural angiography showed complete occlusion of metastatic blood supply and greater than 80% devascularization of the lesions. Greater than 50% reduction of pain score and analgesic doses was achieved in 97% of procedures. The mean duration of pain relief was 8.1 months (range 1-12 months). The mean maximal tumor diameter after embolization was 5.5 cm (range 2-20 cm). Variable ossification appeared in 65 patients. Postembolization syndrome, ischemic pain at the site of embolization, paresthesias, skin breakdown, and subcutaneous necrosis were observed in 87 patients. CONCLUSIONS: Selective embolization with NBCA is a safe and effective palliative treatment for metastatic bone lesions of various primary cancers; pain relief is temporary.


Subject(s)
Bone Neoplasms/therapy , Embolization, Therapeutic , Enbucrilate/therapeutic use , Adult , Aged , Aged, 80 and over , Angiography, Digital Subtraction , Bone Neoplasms/complications , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/secondary , Disease Progression , Embolization, Therapeutic/adverse effects , Enbucrilate/adverse effects , Female , Humans , Italy , Male , Middle Aged , Pain Measurement , Pain, Intractable/etiology , Pain, Intractable/therapy , Palliative Care , Recurrence , Retrospective Studies , Time Factors , Tomography, X-Ray Computed , Treatment Outcome , Young Adult
2.
World J Radiol ; 2(10): 399-404, 2010 Oct 28.
Article in English | MEDLINE | ID: mdl-21161025

ABSTRACT

AIM: To assess radiologists reporting rates of incidental vertebral compression fractures in imaging studies. METHODS: We performed a review of the current literature on the prevalence and reporting rates of incidental vertebral compression fractures in radiologic examinations. RESULTS: The bibliographic search revealed 12 studies: 7 studies using conventional radiology and 5 using multidetector computed tomography (MDCT). The loss of height cut-off to define a vertebral fracture varied from 15% to 25%. Fracture prevalence was high (mean 21.1%; range 9.5%-35%) in both radiographic and MDCT studies (mean 21.6% and 20.2%, respectively). Reporting rates were low with a mean value of 27.4% (range 0%-66.3%) and were significantly lower in MDCT than in radiographic studies (mean 8.1% vs 41.1%). Notably, recent studies showed lower reporting rates than older studies. CONCLUSION: Many scientific studies have confirmed a high prevalence of vertebral compression fractures as incidental findings on imaging studies. However, the underreporting of these fractures, as determined in our study, may negatively affect patient care.

SELECTION OF CITATIONS
SEARCH DETAIL
...